245 related articles for article (PubMed ID: 30300141)
81. Caveolin-2 deficiency induces a rapid anti-tumor immune response prior to regression of implanted murine lung carcinoma tumors.
Liu Y; Qi X; Li G; Sowa G
Sci Rep; 2019 Dec; 9(1):18970. PubMed ID: 31831780
[TBL] [Abstract][Full Text] [Related]
82. Cellular and vaccine immunotherapy for multiple myeloma.
Garfall AL; Stadtmauer EA
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):521-527. PubMed ID: 27913524
[TBL] [Abstract][Full Text] [Related]
83. Impact of TCR Diversity on the Development of Transplanted or Chemically Induced Tumors.
Schreiber K; Karrison TG; Wolf SP; Kiyotani K; Steiner M; Littmann ER; Pamer EG; Kammertoens T; Schreiber H; Leisegang M
Cancer Immunol Res; 2020 Feb; 8(2):192-202. PubMed ID: 31831634
[TBL] [Abstract][Full Text] [Related]
84. Monoclonal TCR-redirected tumor cell killing.
Liddy N; Bossi G; Adams KJ; Lissina A; Mahon TM; Hassan NJ; Gavarret J; Bianchi FC; Pumphrey NJ; Ladell K; Gostick E; Sewell AK; Lissin NM; Harwood NE; Molloy PE; Li Y; Cameron BJ; Sami M; Baston EE; Todorov PT; Paston SJ; Dennis RE; Harper JV; Dunn SM; Ashfield R; Johnson A; McGrath Y; Plesa G; June CH; Kalos M; Price DA; Vuidepot A; Williams DD; Sutton DH; Jakobsen BK
Nat Med; 2012 Jun; 18(6):980-7. PubMed ID: 22561687
[TBL] [Abstract][Full Text] [Related]
85. A STING-activating nanovaccine for cancer immunotherapy.
Luo M; Wang H; Wang Z; Cai H; Lu Z; Li Y; Du M; Huang G; Wang C; Chen X; Porembka MR; Lea J; Frankel AE; Fu YX; Chen ZJ; Gao J
Nat Nanotechnol; 2017 Jul; 12(7):648-654. PubMed ID: 28436963
[TBL] [Abstract][Full Text] [Related]
86. Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple Myeloma.
Welters C; Lammoglia Cobo MF; Stein CA; Hsu MT; Ben Hamza A; Penter L; Chen X; Buccitelli C; Popp O; Mertins P; Dietze K; Bullinger L; Moosmann A; Blanc E; Beule D; Gerbitz A; Strobel J; Hackstein H; Rahn HP; Dornmair K; Blankenstein T; Hansmann L
Cancer Immunol Res; 2022 Nov; 10(11):1407-1419. PubMed ID: 36122410
[TBL] [Abstract][Full Text] [Related]
87. Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression.
Calcinotto A; Brevi A; Chesi M; Ferrarese R; Garcia Perez L; Grioni M; Kumar S; Garbitt VM; Sharik ME; Henderson KJ; Tonon G; Tomura M; Miwa Y; Esplugues E; Flavell RA; Huber S; Canducci F; Rajkumar VS; Bergsagel PL; Bellone M
Nat Commun; 2018 Dec; 9(1):4832. PubMed ID: 30510245
[TBL] [Abstract][Full Text] [Related]
88. Regulatory T cells suppress myeloma-specific immunity during autologous stem cell mobilization and transplantation.
Takahashi S; Minnie SA; Ensbey KS; Schmidt CR; Sekiguchi T; Legg SRW; Zhang P; Koyama M; Olver SD; Collinge AD; Keshmiri S; Comstock ML; Varelias A; Green DJ; Hill GR
Blood; 2024 Apr; 143(16):1656-1669. PubMed ID: 38295333
[TBL] [Abstract][Full Text] [Related]
89. CD8+ T cells specific for cancer germline gene antigens are found in many patients with multiple myeloma, and their frequency correlates with disease burden.
Goodyear O; Piper K; Khan N; Starczynski J; Mahendra P; Pratt G; Moss P
Blood; 2005 Dec; 106(13):4217-24. PubMed ID: 16144804
[TBL] [Abstract][Full Text] [Related]
90. Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies.
Guillerey C; Nakamura K; Vuckovic S; Hill GR; Smyth MJ
Cell Mol Life Sci; 2016 Apr; 73(8):1569-89. PubMed ID: 26801219
[TBL] [Abstract][Full Text] [Related]
91. A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma.
Noonan K; Marchionni L; Anderson J; Pardoll D; Roodman GD; Borrello I
Blood; 2010 Nov; 116(18):3554-63. PubMed ID: 20664052
[TBL] [Abstract][Full Text] [Related]
92. Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma.
Larrayoz M; Garcia-Barchino MJ; Celay J; Etxebeste A; Jimenez M; Perez C; Ordoñez R; Cobaleda C; Botta C; Fresquet V; Roa S; Goicoechea I; Maia C; Lasaga M; Chesi M; Bergsagel PL; Larrayoz MJ; Calasanz MJ; Campos-Sanchez E; Martinez-Cano J; Panizo C; Rodriguez-Otero P; Vicent S; Roncador G; Gonzalez P; Takahashi S; Katz SG; Walensky LD; Ruppert SM; Lasater EA; Amann M; Lozano T; Llopiz D; Sarobe P; Lasarte JJ; Planell N; Gomez-Cabrero D; Kudryashova O; Kurilovich A; Revuelta MV; Cerchietti L; Agirre X; San Miguel J; Paiva B; Prosper F; Martinez-Climent JA
Nat Med; 2023 Mar; 29(3):632-645. PubMed ID: 36928817
[TBL] [Abstract][Full Text] [Related]
93. CXCL10 Recruitment of γδ T Cells into the Hypoxic Bone Marrow Environment Leads to IL17 Expression and Multiple Myeloma Progression.
Wang J; Peng Z; Guo J; Wang Y; Wang S; Jiang H; Wang M; Xie Y; Li X; Hu M; Xie Y; Cheng H; Li T; Jia L; Song J; Wang Y; Hou J; Liu Z
Cancer Immunol Res; 2023 Oct; 11(10):1384-1399. PubMed ID: 37586075
[TBL] [Abstract][Full Text] [Related]
94. Diet-induced obesity reduces bone marrow T and B cells and promotes tumor progression in a transplantable Vk*MYC model of multiple myeloma.
Nedal TMV; Moen SH; Roseth IA; Tryggestad SS; Aass KR; Hov GG; Hella H; Sponaas AM; Standal T
Sci Rep; 2024 Feb; 14(1):3643. PubMed ID: 38351079
[TBL] [Abstract][Full Text] [Related]
95. Immunity and protection, the unfolding of a tale.
Zanetti M
Immunol Res; 2007; 38(1-3):305-18. PubMed ID: 17917038
[TBL] [Abstract][Full Text] [Related]
96. Immunoregulatory roles of versican proteolysis in the myeloma microenvironment.
Hope C; Foulcer S; Jagodinsky J; Chen SX; Jensen JL; Patel S; Leith C; Maroulakou I; Callander N; Miyamoto S; Hematti P; Apte SS; Asimakopoulos F
Blood; 2016 Aug; 128(5):680-5. PubMed ID: 27259980
[TBL] [Abstract][Full Text] [Related]
97. Tissue-resident macrophages promote early dissemination of multiple myeloma via IL-6 and TNFα.
Akhmetzyanova I; Aaron T; Galbo P; Tikhonova A; Dolgalev I; Tanaka M; Aifantis I; Zheng D; Zang X; Fooksman D
Blood Adv; 2021 Sep; 5(18):3592-3608. PubMed ID: 34550328
[TBL] [Abstract][Full Text] [Related]
98. Relapsed multiple myeloma demonstrates distinct patterns of immune microenvironment and malignant cell-mediated immunosuppression.
Visram A; Dasari S; Anderson E; Kumar S; Kourelis TV
Blood Cancer J; 2021 Mar; 11(3):45. PubMed ID: 33649314
[TBL] [Abstract][Full Text] [Related]
99. Uptake of long-chain fatty acids from the bone marrow suppresses CD8+ T-cell metabolism and function in multiple myeloma.
Gudgeon N; Giles H; Bishop EL; Fulton-Ward T; Escribano-Gonzalez C; Munford H; James-Bott A; Foster K; Karim F; Jayawardana D; Mahmood A; Cribbs AP; Tennant DA; Basu S; Pratt G; Dimeloe S
Blood Adv; 2023 Oct; 7(20):6035-6047. PubMed ID: 37276076
[TBL] [Abstract][Full Text] [Related]
100. Identification of pluripotent and adult stem cell genes unrelated to cell cycle and associated with poor prognosis in multiple myeloma.
Kassambara A; Hose D; Moreaux J; Rème T; Torrent J; Rossi JF; Goldschmidt H; Klein B
PLoS One; 2012; 7(7):e42161. PubMed ID: 22860071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
